June 28 - July 1, 2006
Individual abstracts are available for viewing/download by
clicking on the nominees name.
Wednesday - Arrival
1900
Reception
Thursday - Scientific Sessions
0830 - 1000
I
Challenge of Glaucoma in the Developing World Co-Chairs: Sommer, Resnikoff
Sommer: Introduction and background
Resnikoff (WHO): The Major Causes
of Blindness in the World Quigley: Prevalence and burden of
glaucoma Robin: Access to care-availability
and costs of surgical and medical treatments,
and patient compliance Friedman: A “modest proposal”
for WHO guidelines and
recommendations for the prevention
and treatment of glaucoma
1000 - 1030
Break
1030 - 1200
II
Epidemiology of world wide glaucoma
Co-Chairs: Wormald, Quigley(Pre-circulated material)
Supporting documents are now available in this secure
folder
Please use the user name and password which were sent
to you in the
last 48 hours by Rich Parish
In this session, the presentations will be brief and
the discussion will be
very interactive.
Open Angle Glaucoma
Organization of care in 3 settings:
highly developed countries
intermediate
most disadvanyaged countries
Angle Closure Glaucoma The need to develop
evidence on which we can base whom to treat
with iridotomy and other therapy
Please CLICK
HERE to access material of published papers and
proceedings of past relevant meetings that should be
reviewed prior to the meeting so that the discussion
will be more focused and relevant.
1200 - 1330
Lunch
1330 - 1500
III
Identification and screening
Co-Chairs: Weinreb, Seah
Screening For Open Angle Glaucoma Wilson:
Background
Is screening Feasible for Open Angle
Glaucoma? Coleman:
IOP and Risk Analysis Heijl:
Visual Fields Zangwill:
Imaging Lee - Yes Hitchings No
Is Screening Feasible for Angle Closure
Glaucoma? Friedman:
Conventional Approaches Aung:
New screening modalities Foster - Yes Thomas - No
1530 - 1700
IV
Presentations by Society nominees 5 presentations - each 11 minutes
with 7 minute discussion
1530 - 1541
Edward:
Clinical Course of Bimatoprost-Induced Periocular Skin
Changes in Caucasia
1548 - 1559
Garudadri:
Effect of optic disc size on the diagnostic capability
of the
imaging technologies in glaucoma
1606 - 1617
Johnson,
C: Normal Age-Related Sensitivity for a Variety
of Visual
Functions Throughout the Visual Field
1624 - 1635
Johnson,
D: Prostaglandins increase outflow facility in cultured
human
anterior segments
1642 - 1653
Kee: Injection
of Cultured Autologous Fibroblasts into the Subconjunctival
Space of Rabbits Treated with Mitomycin
C
Friday - Scientific Sessions
0800 - 1000
V - Basic Science considerations
Co-Chairs: Chauhan, Tamm
Burgoyne: What really defines glaucomatous
Cupping
Epstein: A New Hypothesis about Glaucoma
Weinreb: The Mouse in Glaucoma Research
Chauhan: Endothelin and experimental optic
nerve damage O’Brien: Gene Expression
Studies in Optic Nerve Cells in Glaucoma
Tamm: Bone Morphogenetic Protein 7 is an
Endogenous Antagonist of Transforming
Growth Factor 2 in Trabecular Meshwork Cells and Tenon’s
Fibroblasts
Kaufman: Caldesmon – A New Target for
Gene Therapy in Glaucoma
1000 - 1030
Break
1030 - 1200
VI - Presentations by Society nominees 5 presentations - each 11 minutes
with 7 minute discussion
1030
- 1041
Kwon: Automatic
cup-to-disc segmentation from stereo color fundus
photographs using pixel feature classification
algorithm
Nicolela:
Prospective longitudinal study in glaucoma patients
with specific
optic disc phenotypes: Baseline characteristics
and endothelin-1 related
vascular reactivity
1124
- 1135
Richards:
Expression Profile Approach to Glaucoma Gene Detection
1142
- 1153
Robin: Anecortave
Acetate: Both a Novel Agent and Novel Delivery
System: Pilot Studies in Glaucoma
1200 - 1400
Luncheon and Business meeting
1400
- 1430
GOLDMANN LECTURE:
The Glaucoma Graph
Professor Roger Hitchings
1430 - 1500
Break
1500 - 1700
VII - Pharmacologic treatment worldwide issues
Co-Chairs: Podos, Kaufman Guest Panelist: Stephen Drance
Lee: Need - Epidemiologic, Demographic and
Geographic
Considerations
Robin: Availability: Getting Therapies to
Those Who Need It
Coleman: Cost - To Patients, Countries and
Society Who Manufactures and Pays - Industry’s
Role Scott Whitcup, Kevin Buehler,
Jack McMillan
Wilson: Pharmacogenetics and Ethnicity
Epstein: The Role of Scientific Discovery
Tuulonen: The Role of the Internet and Telemedicine
Saturday - Scientific Sessions
0800 - 1000
VIII - Improving Surgical Care throughout
the World
Co-Chairs: Khaw, Grehn
Grehn: Surgical Approaches to Childhood Glaucoma
Around the World
Khaw: Should Anti-Scarring Therapies be Used
in Every Glaucoma
Surgery Performed Around the World
Quigley: Rational Approach to Glaucoma Surgery
in Africa
Gandolfi: Is Non Penetrating Surgery Realistic
for the Worldwide
Surgical Treatment of Glaucoma?
Minckler: Devices – Are These a Realistic
Approach to Surgery Around
the World?
Aung: Surgical Approaches to Angle Closure
Glaucoma
1000 - 1030
Break
1030 - 1130
IX - Presentations by Society nominees
4 presentations – each 10 minutes with 5 minute
discussion
1030
- 1040
Schuman:
High-Speed, Ultra-High Resolution Optical Coherence
Tomography in Glaucoma
1045
- 1055
Sugiyama:
Circadian intraocular pressure rhythm is generated by
clock genes
1100 - 1110
Yu: Pathways
And Mechanisms Of Glaucoma Micro Drainage Surgery
1115
- 1120
Jampel:
Depression and mood indicators in newly diagnosed glaucoma
patients
1130 - 1300
X - Defining Progression in glaucoma Are uniform worldwide standards possible?
Co-Chairs: Anderson, Garway-Heath
Sekhar: Present Methods Used Clinically for
Monitoring Glaucoma in the Parts
of the World Familiar to me.
Drance: Present Methods Used Clinically for
Monitoring Glaucoma in the Parts of
the World Familiar to me.
Heijl: Obstacles to use of Visual Field Testing
for Monitoring Progression
Chauhan: Obstacles to use Optic Disc Appearance
to Monitor Progression
Caprioli: Potential for new Technologies for
Monitoring Glaucoma in Various Clinical
and Research Settings
Panel Discussion (30min): Speakers and other
Society Members
Challenge of Glaucoma in the Developing World